The subcutaneous drug delivery system is a viable route for the administration of drugs with poor solubility. However, the process of absorption has not been extensively studied. Consequently, there are no established models to predict drug absorption. Instead, pharmacology researchers have relied on multiple empirical experiments to assess the efficacy and safety of SC injection.
The global subcutaneous medicine delivery market is led by the United States and Europe. However, Asia Pacific is expected to witness the fastest growth during this period. Due to growing awareness among people, Asia Pacific will be one of the fastest-growing regions. It is anticipated that by 2030, there will be over 439 million people living with diabetes. The region will experience significant growth during this timeframe. While North America is the largest regional market, China is expected to continue to lead the pack.
Read More:
https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933
Click here for Subcutaneous Drug Delivery Market Report:
https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933
Click here for Subcutaneous Drug Delivery Market Press Release:
